These results highlight the importance of the PD-1/PD-L1 pathway in suppressing immunity to the 5T33 myeloma, and they support our model that ongoing checkpoint blockade is needed to maintain the function of activated tumor-specific CD8 cells long enough for them to eliminate the myeloma cells and generate memory. This evidence concerns the gene CD274 and neoplasm.